Real-time nucleic acid detection processes and compositions
    2.
    发明授权
    Real-time nucleic acid detection processes and compositions 有权
    实时核酸检测方法和组合物

    公开(公告)号:US09261460B2

    公开(公告)日:2016-02-16

    申请号:US10096076

    申请日:2002-03-12

    IPC分类号: C12P19/34 G01N21/64 C12Q1/68

    摘要: This invention provides compositions for use in real time nucleic acid detection processes. Such real time nucleic acid detection processes are carried out with energy transfer elements attached to nucleic acid primers, nucleotides, nucleic acid probes or nucleic acid binding agents. Real time nucleic acid detection allows for the qualitative or quantitative detection or determination of single-stranded or double-stranded nucleic acids of interest in a sample. Other processes are provided by this invention including processes for removing a portion of a homopolymeric sequence, e.g., poly A sequence or tail, from an analyte or library of analytes. Compositions useful in carrying out such removal processes are also described and provided.

    摘要翻译: 本发明提供用于实时核酸检测过程的组合物。 这种实时核酸检测方法是用连接于核酸引物,核苷酸,核酸探针或核酸结合剂的能量转移元件进行的。 实时核酸检测允许定性或定量检测或测定样品中感兴趣的单链或双链核酸。 本发明提供了其它方法,包括从被分析物或分析物库中除去一部分均聚物序列,例如聚A序列或尾部的方法。 还描述和提供了用于进行这种去除方法的组合物。

    Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
    3.
    发明授权
    Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses 失效
    性能影响和/或性能表现出用于治疗和诊断用途的组合物

    公开(公告)号:US08742090B2

    公开(公告)日:2014-06-03

    申请号:US08978632

    申请日:1997-11-25

    IPC分类号: C07H21/04

    摘要: The present invention provides an array of compositions useful for effecting and/or exhibiting changes in biological functioning and processing within cells and in biological systems containing such cells. In effect, these compositions combine chemical modifications and/or ligand additions with biological functions. The chemical modifications and/or ligand additions provide additional characteristics to the compositions without interfering substantially with their biological function. Such additional characteristics include nuclease resistance, targeting specific cells or specific cell receptors localizing to specific sites within cells and augmenting interactions between the compositions and target cells of interest as well as decreasing such interactions when desired. Also provided by the present invention are processes and kits.

    摘要翻译: 本发明提供了一组组合物,其用于在细胞内和含有这种细胞的生物系统中实现和/或表现出生物功能和加工中的变化。 实际上,这些组合物将化学修饰和/或配体添加与生物学功能相结合。 化学修饰和/或配体添加为组合物提供额外的特征,而不会基本上干扰它们的生物学功能。 这样的附加特征包括核酸酶抗性,靶向特定细胞或定位于细胞内特定位点的特定细胞受体,并且增加组合物和靶细胞之间的相互作用,并且当需要时减少这种相互作用。 本发明还提供了方法和试剂盒。

    Therapeutic processes and useful compositions therefor
    9.
    发明授权
    Therapeutic processes and useful compositions therefor 有权
    治疗方法及其有用的组合物

    公开(公告)号:US07608274B2

    公开(公告)日:2009-10-27

    申请号:US10470611

    申请日:2003-12-08

    IPC分类号: A61K39/29

    摘要: This invention provides novel processes for therapeutic applications, including the treatment of subjects carrying infectious agents or having impaired autoimmunity or impaired immune condition. The therapeutic applications disclosed herein are also directed at the treatment of cancerous subjects with malignant tumors containing cancerous cells or malignant or cancerous cells. Vaccination processes for preventing infections in subjects are also provided. The novel processes comprise introducing into or administering to a subject one or more antigens, or trained or adopted immune cells. These antigens or immune cells are capable of establishing or increasing at least one first specific immune response and decreasing at least one second specific immune response. Such responses include components, such as cellular immune reaction elements, humoral immune reaction elements and cytokines, the latter also encompassing interferons and lymphokines. Useful compositions are also provided by this invention.

    摘要翻译: 本发明提供了用于治疗应用的新方法,包括治疗携带感染性物质或具有受损的自身免疫或免疫病症受损的受试者。 本文公开的治疗应用还涉及用含有癌细胞或恶性或癌细胞的恶性肿瘤治疗癌性受试者。 还提供了预防受试者感染的疫苗接种过程。 所述新方法包括向受试者引入或施用一种或多种抗原或训练或采用的免疫细胞。 这些抗原或免疫细胞能够建立或增加至少一种第一特异性免疫应答并减少至少一种第二特异性免疫应答。 这些反应包括组分,如细胞免疫反应元件,体液免疫反应元件和细胞因子,后者还包括干扰素和淋巴因子。 本发明也提供有用的组合物。

    Cell line for producing a non-retroviral vector
    10.
    发明申请
    Cell line for producing a non-retroviral vector 审中-公开
    用于产生非逆转录病毒载体的细胞系

    公开(公告)号:US20090263895A1

    公开(公告)日:2009-10-22

    申请号:US12075482

    申请日:2008-03-12

    IPC分类号: C12N5/08

    摘要: Provided are novel vectors and viral vectors capable of expressing exogenous gene or exogenous nucleic acid sequences in a target cell of interest, such as T cells, bone marrow cells, epithelial cells, liver cells and the like. The nucleic acid components of the vectors may include one or more native promoter/enhancer regions having modified sequence segments, one or more non-native promoter/enhancer or non-native promoter's gene or gene segment, and a native viral vector terminator or processing signal or segment thereof. The viral vectors comprise a virus or viral portion having on the surfaces or envelopes adsorption components, one for a packaging cell line and the other for delivery to a target cell. Other viral vectors provided by this invention have two components on their surfaces or envelopes, one of which is native to the virus and the other being non-native and capable of adsorbing to the target cell while being incapable of adsorbing to a native cell for the viral vector. Packaging cell lines for propagating the vectors and viral vectors are also provided, as are novel processes for propagating any of the disclosed vectors or viral vectors.

    摘要翻译: 提供能够在靶细胞中表达外源基因或外源核酸序列的新载体和病毒载体,例如T细胞,骨髓细胞,上皮细胞,肝细胞等。 载体的核酸组分可以包括一个或多个具有修饰的序列区段的天然启动子/增强子区域,一个或多个非天然启动子/增强子或非天然启动子的基因或基因区段,以及天然病毒载体终止子或处理信号 或其片段。 病毒载体包含在表面或包膜上具有吸附组分的病毒或病毒部分,一个用于包装细胞系,另一个用于递送至靶细胞。 本发明提供的其它病毒载体在其表面或包膜上具有两个组分,其中一个组分是病毒天然的,另一个是非天然的,并且能够吸附到靶细胞,同时不能吸附到天然细胞中 病毒载体。 还提供用于繁殖载体和病毒载体的包装细胞系,以及用于繁殖任何所公开的载体或病毒载体的新方法。